Your browser doesn't support javascript.
loading
Efficacy and safety of ipragliflozin as add-on to metformin for type 2 diabetes: a meta-analysis of double-blind randomized controlled trials.
Chen, Weiping; Li, Pengyun; Wang, Guoqi; Chen, Yang; Wang, Bin; Chen, Mulan.
Afiliación
  • Chen W; Department of Clinical Medicine, Southwest Medical University, Luzhou, Sichuan, China.
  • Li P; Key Laboratory of Medical Electrophysiology, Ministry of Education, and Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, China.
  • Wang G; Department of Clinical Medicine, Southwest Medical University, Luzhou, Sichuan, China.
  • Chen Y; Department of Clinical Medicine, Southwest Medical University, Luzhou, Sichuan, China.
  • Wang B; Department of Clinical Medicine, Southwest Medical University, Luzhou, Sichuan, China.
  • Chen M; Department of Clinical Medicine, Southwest Medical University, Luzhou, Sichuan, China.
Postgrad Med ; 131(8): 578-588, 2019 Nov.
Article en En | MEDLINE | ID: mdl-31414934
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiofenos / Diabetes Mellitus Tipo 2 / Glucósidos / Hipoglucemiantes / Metformina Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Postgrad Med Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiofenos / Diabetes Mellitus Tipo 2 / Glucósidos / Hipoglucemiantes / Metformina Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Postgrad Med Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido